日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy

从基于多替拉韦的疗法换用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺疗法

Orkin, Chloe; Antinori, Andrea; Rockstroh, Jürgen K; Moreno-Guillén, Santiago; Martorell, Claudia T; Molina, Jean-Michel; Lazzarin, Adriano; Maggiolo, Franco; Yazdanpanah, Yazdan; Andreatta, Kristen; Huang, Hailin; Hindman, Jason T; Martin, Hal; Pozniak, Anton

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺作为 HIV-1 初始治疗:两项随机试验的五年随访结果

Sax, Paul E; Arribas, José R; Orkin, Chloe; Lazzarin, Adriano; Pozniak, Anton; DeJesus, Edwin; Maggiolo, Franco; Stellbrink, Hans-Jürgen; Yazdanpanah, Yazdan; Acosta, Rima; Huang, Hailin; Hindman, Jason T; Martin, Hal; Baeten, Jared M; Wohl, David

Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice

临床实践中从非蛋白酶抑制剂方案转换为达芦那韦/考比司他/恩曲他滨/替诺福韦艾拉酚胺固定剂量组合方案

Ranzenigo, Martina; Gianotti, Nicola; Galli, Laura; Poli, Andrea; Mastrangelo, Andrea; Bruzzesi, Elena; Chiurlo, Matteo; Nozza, Silvia; Bossolasco, Simona; Spagnuolo, Vincenzo; Mancusi, Daniela; Termini, Roberta; Carini, Elisabetta; Lazzarin, Adriano; Castagna, Antonella

Benefits of a 12 week physical activity programme on muscle and bone health in people living with HIV

一项为期 12 周的体育锻炼计划对 HIV 感染者的肌肉和骨骼健康有益

Bonato, Matteo; Galli, Laura; Bossolasco, Simona; Bertocchi, Cecilia; Balconi, Giuseppe; Borderi, Marco; Viale, Pierluigi; Pavei, Gaspare; Merati, Giampiero; La Torre, Antonio; Lazzarin, Adriano; Banfi, Giuseppe; Cinque, Paola

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

新冠肺炎住院患者的继发感染:发生率和预测因素

Ripa, Marco; Galli, Laura; Poli, Andrea; Oltolini, Chiara; Spagnuolo, Vincenzo; Mastrangelo, Andrea; Muccini, Camilla; Monti, Giacomo; De Luca, Giacomo; Landoni, Giovanni; Dagna, Lorenzo; Clementi, Massimo; Rovere Querini, Patrizia; Ciceri, Fabio; Tresoldi, Moreno; Lazzarin, Adriano; Zangrillo, Alberto; Scarpellini, Paolo; Castagna, Antonella

Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy

意大利北部移民人群中HIV-1感染的分子流行病学

Sagnelli, Caterina; Uberti-Foppa, Caterina; Bagaglio, Sabrina; Cella, Eleonora; Scolamacchia, Vittoria; Hasson, Hamid; Salpietro, Stefania; Messina, Emanuela; Morsica, Giulia; Angeletti, Silvia; Ciccozzi, Massimo; Lazzarin, Adriano; Sagnelli, Evangelista

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study

在病毒学治疗失败的 HIV-1 感染患者中,多替拉韦联合利托那韦增强的阿扎那韦的核苷类药物替代方案:DOLATAV 研究

Spagnuolo, Vincenzo; Galli, Laura; Poli, Andrea; Bigoloni, Alba; Fumagalli, Luca; Gianotti, Nicola; Nozza, Silvia; Ferrari, Davide; Locatelli, Massimo; Lazzarin, Adriano; Castagna, Antonella

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2

奥比他韦、帕立普韦联合利托那韦±达沙布韦(含或不含利巴韦林)治疗人类免疫缺陷病毒-1型和丙型肝炎病毒基因1型或基因4型合并感染患者的安全性和有效性:TURQUOISE-I 第2部分

Rockstroh, Jürgen K; Orkin, Chloe; Viani, Rolando M; Wyles, David; Luetkemeyer, Anne F; Lazzarin, Adriano; Soto-Malave, Ruth; Nelson, Mark R; Bhagani, Sanjay R; Klinker, Hartwig H F; Rizzardini, Giuliano; Girard, Pierre-Marie; Tural, Cristina; Shulman, Nancy S; Mobashery, Niloufar; Hu, Yiran B; Fredrick, Linda M; Pilot-Matias, Tami; Trinh, Roger; Gane, Edward

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients

大麻素受体2-63 RR变异体与HIV/HCV合并感染患者的严重坏死性炎症独立相关

Sagnelli, Caterina; Uberti-Foppa, Caterina; Hasson, Hamid; Bellini, Giulia; Minichini, Carmine; Salpietro, Stefania; Messina, Emanuela; Barbanotti, Diletta; Merli, Marco; Punzo, Francesca; Coppola, Nicola; Lazzarin, Adriano; Sagnelli, Evangelista; Rossi, Francesca

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients

对初治和经治 HIV 感染者进行多替拉韦联合骨干方案与拉替拉韦联合骨干方案、达芦那韦+利托那韦联合骨干方案以及依非韦伦/替诺福韦/恩曲他滨方案的成本效益分析

Restelli, Umberto; Rizzardini, Giuliano; Antinori, Andrea; Lazzarin, Adriano; Bonfanti, Marzia; Bonfanti, Paolo; Croce, Davide